Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

STROKECELLFUSION

Financiado

Cerrado

Cell fusion as regenerative tool for stroke treatment

In the last years it has been shown that transplanted adult bone marrow derived stem cells (BMSCs) have the ability to fuse with cells of other types and restore several pathologies such as congenital liver failure and muscular dy... ver más

30/06/2012

CSIC

153K€

Presupuesto del proyecto: 153K€

Líder del proyecto

AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGA... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 2-3 | 552M€

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2012-06-30 No tenemos la información de la convocatoria

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

CSIC

0.00€ | Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

BEND Bendable Bioplatform for Electrically stimulated Neuronal Di... 195K€ Cerrado

BFU2016-78327-P ESPEFICIACION NEURONAL DESDE CELULAS MADRE NEURALES. ¿POR QU... 230K€ Cerrado

STEMFORSTROKE Secretome analysis of intrathecally applied bone marrow stro... 169K€ Cerrado

PID2019-106943RB-I00 PROTECCION NEURONAL MULTIFACTORIAL: SINERGIA ENTRE MOLECULAS... 109K€ Cerrado

Reprogramming for PD Cell fusion mediated reprogramming as neuronal rescue mechan... 167K€ Cerrado

RYC2020-029831-I Neural cell lineages and cell therapy 324K€ Cerrado

Líder del proyecto

AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGA... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 2-3 | 552M€

Presupuesto del proyecto 153K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto In the last years it has been shown that transplanted adult bone marrow derived stem cells (BMSCs) have the ability to fuse with cells of other types and restore several pathologies such as congenital liver failure and muscular dystrophy. On the nervous system, it was recently reported that bone marrow transplantation (BMT) made 24 hours after the stroke leads to a functional outcome. Cell fusion is one of the underlying mechanisms as it has been shown that it is indirectly implicated in the formation of vasculature after stroke. Thus, stroke is a pathology susceptible to be treated with this cell therapy mechanism. Despite the great potential of this mechanism of regeneration, the low frequency of fusion events, especially in the brain, has veiled and hindered the true regenerative potential of cell fusion. Therefore, the main objective of this project is to identify fusogenic factors that will increase cell fusion events to an effective level for cell therapy of neurological disorders. For this, firstly we will screen in vitro new putative fusogenic with the help of an in vitro cell fusion detection system and FACS analysis. Later, chitosan nanoparticles will be developed for the controlled release of the putative fusogenic factors. Finally, we will evaluate the in vivo efficacy of these factors trough a series of intravenous BMT co-administered with nanoparticles loaded with the selected factors in the mouse model of stroke. We will correlate an increment in the cell fusion events with the putative improvement in stroke symptoms. With this project we will improve our knowledge about adult stem cell plasticity and explore cell fusion process as a neuroregenerative process for the treatment of stroke.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores